Stock listing
Cue Biopharma, Inc.
- Ticker
- NASDAQ:CUE
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Cue Biopharma, Inc.
Cue Biopharma, Inc. is a public company traded under the ticker CUE on the American market. Cue Biopharma focuses on developing innovative therapies for cancer and autoimmune diseases.
Latest news from Cue Biopharma, Inc.
Cue Biopharma Announces Positive Topline Results from CUE-221 Phase 2 Study in Chronic Spontaneous Urticaria
Sep 20, 2026
Cue Biopharma Announces Appointment of James M. Ahlers as Chief Financial Officer and CUE-221 Investigational New Drug Submission
Aug 3, 2026
Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development
Jul 13, 2026
Cue Biopharma Announces $50.0 Million Private Placement
Jul 9, 2026